Literature DB >> 8910870

The antistaphylococcal effect of nisin in a suitable vehicle: a potential therapy for atopic dermatitis in man.

C Valenta1, A Bernkop-Schnürch, H P Rigler.   

Abstract

Staphylococcus aureus plays a central role in the pathogenesis of atopic dermatitis and is the predominant microorganism both in the lesions and in adjacent clinically normal skin. Chronic infection might aggravate the underlying lesion and serve as a source for further S. aureus infection. Nisin is a non-toxic and non-irritant peptide with no antibiotic-like side effects. In this study the antistaphylococcal activity of nisin in six topical formulations was investigated in diffusion tests and is shown to depend both on the water content and on the technological system. Because topical products often adhere to the stratum corneum for only a short time, the kinetics of antimicrobial activity were examined using a membrane filter technique. Thirty minutes after nisin addition almost no living microorganisms were detectable in different aqueous samples. The results demonstrate the potential of nisin preparations as an alternative to common antibiotics in the treatment of S. aureus infections in atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910870     DOI: 10.1111/j.2042-7158.1996.tb06019.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Production of active chimeric pediocin AcH in Escherichia coli in the absence of processing and secretion genes from the Pediococcus pap operon.

Authors:  K W Miller; R Schamber; Y Chen; B Ray
Journal:  Appl Environ Microbiol       Date:  1998-01       Impact factor: 4.792

2.  Development of Class IIa Bacteriocins as Therapeutic Agents.

Authors:  Christopher T Lohans; John C Vederas
Journal:  Int J Microbiol       Date:  2011-11-30

3.  Evaluation of Nisin and LL-37 Antimicrobial Peptides as Tool to Preserve Articular Cartilage Healing in a Septic Environment.

Authors:  Ziba Najmi; Ajay Kumar; Alessandro C Scalia; Andrea Cochis; Bojana Obradovic; Federico A Grassi; Massimiliano Leigheb; Meriem Lamghari; Iraida Loinaz; Raquel Gracia; Lia Rimondini
Journal:  Front Bioeng Biotechnol       Date:  2020-06-12

4.  Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells.

Authors:  Jae M Shin; Islam Ateia; Jefrey R Paulus; Hongrui Liu; J Christopher Fenno; Alexander H Rickard; Yvonne L Kapila
Journal:  Front Microbiol       Date:  2015-06-18       Impact factor: 5.640

5.  Dietary nisin modulates the gastrointestinal microbial ecology and enhances growth performance of the broiler chickens.

Authors:  Damian Józefiak; Bartosz Kierończyk; Jerzy Juśkiewicz; Zenon Zduńczyk; Mateusz Rawski; Jakub Długosz; Anna Sip; Ole Højberg
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

6.  Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin.

Authors:  Pachiyappan Kamarajan; Islam Ateia; Jae M Shin; J Christopher Fenno; Charles Le; Ling Zhan; Ana Chang; Richard Darveau; Yvonne L Kapila
Journal:  PLoS Pathog       Date:  2020-10-01       Impact factor: 6.823

Review 7.  Bromelain and Nisin: The Natural Antimicrobials with High Potential in Biomedicine.

Authors:  Urška Jančič; Selestina Gorgieva
Journal:  Pharmaceutics       Date:  2021-12-29       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.